Abstract

Abstract Underlying many chronic inflammatory diseases is the persistence of low-grade inflammation. Low doses of lipopolysaccharide are capable of skewing the immune system towards a pro-inflammatory state without inducing anti-inflammatory compensation. While the cumulative effects of this low-grade endotoxemia can be detrimental, the mechanism is poorly understood. Dysregulation of mitochondrial dynamics has been linked to a variety of diseases and disorders including Parkinson’s and Alzheimer’s. We hypothesized that low-dose LPS induces mitochondrial dysregulation by altering mitochondrial dynamics through an IL-1R-associated kinase-1 and Toll-interacting protein dependent mechanism. To test this hypothesis, we utilized western blotting, immunoprecipation, and confocal microscopy techniques in wild-type and knockout bone marrow derived macrophages. In this study, we demonstrate that subclinical low-dose LPS induces mitochondrial fission while suppressing mitochondrial fusion through IRAK -1 and Tollip. Low-dose LPS causes a decrease in Drp1 phosphorylation while increasing total Drp1 protein levels thus, promoting mitochondrial fission in the wild-type cells. In addition, low-dose LPS inhibits Mfn1 levels further inducing mitochondrial fission. Our data reveals a novel role for low-dose LPS in mitochondrial dynamics, which may contribute to skewed and persistent low-grade inflammation and disease progression.

Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.